Page 7 - In Process Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SELLAS Life Sciences Provides Business Update and Reports Third Quarter 2022 Financial Results

14.11.2022 - – Cash Position of $21.3 Million as of September 30, 2022 – – Hosting Phase 3 REGAL Study Update Webcast Today at 8:30 a.m. ET – NEW YORK, Nov. 14, 2022 (GLOBE NEWSWIRE) - SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or .

United statesHong kongRaquel cona michaela fawcettAngelos stergiouDragan cicicKatherine bach kalinAllison sossBaylor university medical centerSteering committeeGenfleet therapeutics shanghai incAmerican society of hematologyMerck co incStrategic communicationsLife sciences group incD medicines incClinical development

Puma Biotechnology Reports Third Quarter 2022 Financial Results

Raises FY 2022 NERLYNX Net Product Revenue GuidanceLOS ANGELES (BUSINESS WIRE) Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2022. Unless otherwise stated, all comparisons are for the third quarter of 2022 compared to the.

United statesPierre fabreAlanh auerbachEuropean commissionDrug administrationTakeda pharmaceutical companyDevelopment expenseDevelopment expensesExchange commissionPuma biotechnology incEuropean society for medical oncologyProduct revenuePuma biotechnologyChief executive officerMedical oncologyCancer therapeutics

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChristians schadeScottm coiantesrOren giladGregorya korbelsrExchange commissionCompany annual meeting of stockholders onAtrin pharmaceuticals incCompany phaseSecurities exchangeAprea therapeutics incWall streetChief executive officerIn process researchAtrin acquisitionOperations update

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesChristians schadeGregorya korbelOren giladScottm coianteExchange commissionCompany annual meeting of stockholders onAtrin pharmaceuticals incCompany phaseSecurities exchangeAprea therapeutics incSecond quarter financialIn process researchAtrin acquisitionOperations updateAtrin pharmaceuticals

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations

Aprea Therapeutics Reports Second Quarter 2022 Financial Results and Provides Update on Business Operations
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesChristians schadeGregorya korbelOren giladScottm coianteExchange commissionCompany annual meeting of stockholders onAtrin pharmaceuticals incCompany phaseSecurities exchangeAprea therapeutics incChief executive officerIn process researchAtrin acquisitionOperations updateAtrin pharmaceuticals